1. Home
  2. PCSA
  3. PCSA News

Latest Processa Pharmaceuticals Inc. (PCSA) News on June 29, 2025

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering
PCSA

GlobeNewswire

12 days ago

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering

Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate
PCSA

GlobeNewswire

12 days ago

Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
PCSA

GlobeNewswire

16 days ago

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting
PCSA

GlobeNewswire

a month ago

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
PCSA

GlobeNewswire

2 months ago

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
PCSA

GlobeNewswire

3 months ago

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently
PCSA

Insider Monkey

4 months ago

Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
PCSA

GlobeNewswire

5 months ago

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference

Favourable Signals For Processa Pharmaceuticals: Numerous Insiders Acquired Stock
PCSA

Simply Wall St.

5 months ago

Favourable Signals For Processa Pharmaceuticals: Numerous Insiders Acquired Stock

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
PCSA

GlobeNewswire

5 months ago

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
PCSA

GlobeNewswire

5 months ago

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results
PCSA

GlobeNewswire

8 months ago

Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer
PCSA

GlobeNewswire

9 months ago

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer

Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September
PCSA

GlobeNewswire

10 months ago

Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September

Processa Pharmaceuticals Provides Product Pipeline and Financial Update
PCSA

GlobeNewswire

10 months ago

Processa Pharmaceuticals Provides Product Pipeline and Financial Update

Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri
PCSA

GlobeNewswire

10 months ago

Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri

Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer

Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer

Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer

Enhancing the Power of PTZs: Canon Announces New PTZ Firmware Updates Lending Greater Control and Operability, Including an Auto-Tracking Lite Version on Compatible PTZ Models*
PCSA

GlobeNewswire

a year ago

Enhancing the Power of PTZs: Canon Announces New PTZ Firmware Updates Lending Greater Control and Operability, Including an Auto-Tracking Lite Version on Compatible PTZ Models*

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities
PCSA

PR Newswire

a year ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PCSA

Business Wire

a year ago

Form 8.3 - Darktrace plc

PCSA

Business Wire

a year ago

Form 8.3 - International Distribution Services plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win
PCSA

Reuters

a year ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect
PCSA

Investor's Business Daily

a year ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina
PCSA

Business Wire

a year ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

PCSA

GlobeNewswire

a year ago

Middlefield Canadian Income PCC: Net Asset Value(s)

Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research

Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial

Insider Buyers At Processa Pharmaceuticals Recover Some Losses, But Still Down US$40k
PCSA

Simply Wall St.

a year ago

Insider Buyers At Processa Pharmaceuticals Recover Some Losses, But Still Down US$40k

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting

Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

PCSA

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 02/09/2024

Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering

Sensus Healthcare Announces Retirement of Director Samuel O’Rear
PCSA

GlobeNewswire

a year ago

Sensus Healthcare Announces Retirement of Director Samuel O’Rear

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
PCSA

GlobeNewswire

a year ago

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses

11 Hyper-Growth Stocks Billionaires Are Loading Up On
PCSA

Insider Monkey

a year ago

11 Hyper-Growth Stocks Billionaires Are Loading Up On

An Online Marketplace for ‘Many People to Sell Many Things’
PCSA

WWD

a year ago

An Online Marketplace for ‘Many People to Sell Many Things’

Top Building Materials Retailer Contracts Bridgeline for AI-Powered SmartSearch
PCSA

GlobeNewswire

a year ago

Top Building Materials Retailer Contracts Bridgeline for AI-Powered SmartSearch

Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PCSA

GlobeNewswire

a year ago

Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer

Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split

Shareholders in Lifetime Brands (NASDAQ:LCUT) are in the red if they invested three years ago
PCSA

Simply Wall St.

a year ago

Shareholders in Lifetime Brands (NASDAQ:LCUT) are in the red if they invested three years ago

Via Renewables, Inc. Announces Dividend on Preferred Stock
PCSA

ACCESSWIRE

a year ago

Via Renewables, Inc. Announces Dividend on Preferred Stock

Northann Corp. Receives Approval from U.S. Patent and Trademark Office for Core Technology in Benchwick 3D Printing Ecosystem
PCSA

GlobeNewswire

a year ago

Northann Corp. Receives Approval from U.S. Patent and Trademark Office for Core Technology in Benchwick 3D Printing Ecosystem

Kentucky First Federal Bancorp Announces Suspension of Quarterly Cash Dividend
PCSA

GlobeNewswire

a year ago

Kentucky First Federal Bancorp Announces Suspension of Quarterly Cash Dividend

Xcel Brands and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
PCSA

ACCESSWIRE

a year ago

Xcel Brands and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Avikus, Forza X1, Inc. and Twin Vee PowerCats Co. Announce Plans for the Future of Recreational Boating with Autonomous A.I. Technology Partnership
PCSA

ACCESSWIRE

a year ago

Avikus, Forza X1, Inc. and Twin Vee PowerCats Co. Announce Plans for the Future of Recreational Boating with Autonomous A.I. Technology Partnership

Ekso Bionics Announces $4.6 Million Registered Direct Offering
PCSA

GlobeNewswire

a year ago

Ekso Bionics Announces $4.6 Million Registered Direct Offering

Foremost Lithium Receives Multi-Year Work Permit to Commence Drilling on its Jean Lake Lithium/Gold Property
PCSA

GlobeNewswire

a year ago

Foremost Lithium Receives Multi-Year Work Permit to Commence Drilling on its Jean Lake Lithium/Gold Property

ASHFORD TRUST DECLARES PREFERRED DIVIDENDS FOR THE FIRST QUARTER OF 2024
PCSA

PR Newswire

a year ago

ASHFORD TRUST DECLARES PREFERRED DIVIDENDS FOR THE FIRST QUARTER OF 2024

Foremost Lithium Announces Receipt of Third $300,000 Grant from The Manitoba Mineral Development Fund (MMDF)
PCSA

GlobeNewswire

a year ago

Foremost Lithium Announces Receipt of Third $300,000 Grant from The Manitoba Mineral Development Fund (MMDF)

Northann Corp. to Meet Investors, Present Latest 3D Printing Ecosystem and Sustainable Products at TISE2024 in Las Vegas January 24th – 26th, 2024
PCSA

GlobeNewswire

a year ago

Northann Corp. to Meet Investors, Present Latest 3D Printing Ecosystem and Sustainable Products at TISE2024 in Las Vegas January 24th – 26th, 2024

Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12
PCSA

PR Newswire

a year ago

Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12

Processa Pharmaceuticals to Present at the Biotech Showcase 2024
PCSA

GlobeNewswire

a year ago

Processa Pharmaceuticals to Present at the Biotech Showcase 2024

ASLAN Pharmaceuticals Announces Participation in January Investor Conferences
PCSA

GlobeNewswire

a year ago

ASLAN Pharmaceuticals Announces Participation in January Investor Conferences

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
PCSA

GlobeNewswire

2 years ago

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio

ASHFORD TRUST SETS FOURTH QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES
PCSA

PR Newswire

2 years ago

ASHFORD TRUST SETS FOURTH QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES

Wearable Devices Ramps Up Inventory in Anticipation of its Participation at the 2024 CES Showcase
PCSA

GlobeNewswire

2 years ago

Wearable Devices Ramps Up Inventory in Anticipation of its Participation at the 2024 CES Showcase

Super League Announces Private Placement Financing of $8.354 Million and Enters into Accounts Receivable Facility to Further Fund Growth Initiatives
PCSA

GlobeNewswire

2 years ago

Super League Announces Private Placement Financing of $8.354 Million and Enters into Accounts Receivable Facility to Further Fund Growth Initiatives

Rail Vision and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
PCSA

ACCESSWIRE

2 years ago

Rail Vision and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Treasure Global Launches 10 Mini Games Integrated with AI Game Creator in ZCITY’s 3D World, Enters Booming Global Gaming Market
PCSA

GlobeNewswire

2 years ago

Treasure Global Launches 10 Mini Games Integrated with AI Game Creator in ZCITY’s 3D World, Enters Booming Global Gaming Market

United Nations High Commissioner for Refugees Awards Polar Power Initial Contract to Assure Uninterrupted Quality Electric Power for African Offices
PCSA

GlobeNewswire

2 years ago

United Nations High Commissioner for Refugees Awards Polar Power Initial Contract to Assure Uninterrupted Quality Electric Power for African Offices

Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine
PCSA

GlobeNewswire

2 years ago

Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine

Advent Technologies Secures €1.8 Million Frame Contract with Volta Energy for the Supply of Methanol-Powered Fuel Cell Units
PCSA

Business Wire

2 years ago

Advent Technologies Secures €1.8 Million Frame Contract with Volta Energy for the Supply of Methanol-Powered Fuel Cell Units

Wearable Devices Sets New Standard in AR/VR Era with U.S Patent Application for Innovative Touchless Technology
PCSA

GlobeNewswire

2 years ago

Wearable Devices Sets New Standard in AR/VR Era with U.S Patent Application for Innovative Touchless Technology

Insider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)
PCSA

GuruFocus.com

2 years ago

Insider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)

The Dixie Group Reports the Completion of The Sale and Leaseback of Its Facility in Adairsville, GA
PCSA

ACCESSWIRE

2 years ago

The Dixie Group Reports the Completion of The Sale and Leaseback of Its Facility in Adairsville, GA

Inpixon Announces Record Date and Details for Subsidiary Spin-off and its Planned Business Combination with Damon Motors
PCSA

PR Newswire

2 years ago

Inpixon Announces Record Date and Details for Subsidiary Spin-off and its Planned Business Combination with Damon Motors

Advent Technologies Secures Additional New Contract worth $2.8 Million from U.S. Department of Defense for its Portable Fuel Cell System
PCSA

Business Wire

2 years ago

Advent Technologies Secures Additional New Contract worth $2.8 Million from U.S. Department of Defense for its Portable Fuel Cell System

PCSA

CNW Group

2 years ago

Canadian Investment Regulatory Organization Trade Resumption - AEZS

PCSA

CNW Group

2 years ago

Canadian Investment Regulatory Organization Trading Halt - AEZS

Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company
PCSA

GlobeNewswire

2 years ago

Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company

Exela Technologies Recognized as Emerging Solution in FAO Hackett Value Matrix™
PCSA

GlobeNewswire

2 years ago

Exela Technologies Recognized as Emerging Solution in FAO Hackett Value Matrix™

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine
PCSA

GlobeNewswire

2 years ago

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine

RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform
PCSA

Business Wire

2 years ago

RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform

Exela Technologies Named in Forrester’s ‘The Accounts Payable Invoice Automation Landscape, Q1 2024 Report’
PCSA

GlobeNewswire

2 years ago

Exela Technologies Named in Forrester’s ‘The Accounts Payable Invoice Automation Landscape, Q1 2024 Report’

Genius Group Launches AI Education Ecosystem in Partnership with FatBrain AI
PCSA

GlobeNewswire

2 years ago

Genius Group Launches AI Education Ecosystem in Partnership with FatBrain AI

PCSA

Zacks Small Cap Research

2 years ago

TGL: Shareholder Lock-up Agreement as Margins Improve, AI Launches

Treasure Global Makes History with First-Ever AI Robot for TikTok Live Commerce in Malaysia
PCSA

GlobeNewswire

2 years ago

Treasure Global Makes History with First-Ever AI Robot for TikTok Live Commerce in Malaysia

Farmmi Ships Latest Order to Canada; Company Continues to Benefit from Healthy North American Demand
PCSA

PR Newswire

2 years ago

Farmmi Ships Latest Order to Canada; Company Continues to Benefit from Healthy North American Demand

Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now
PCSA

Zacks

2 years ago

Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now

Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
PCSA

GlobeNewswire

2 years ago

Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years

Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
PCSA

GlobeNewswire

2 years ago

Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency

TechPrecision Corporation (PNK:TPCS) Q2 2024 Earnings Call Transcript
PCSA

Insider Monkey

2 years ago

TechPrecision Corporation (PNK:TPCS) Q2 2024 Earnings Call Transcript

These Stocks Are Exploding In The November Stock Market Rally
PCSA

Investor's Business Daily

2 years ago

These Stocks Are Exploding In The November Stock Market Rally

PCSA

PR Newswire

2 years ago

Concord Medical Schedules 2023 Annual Meeting of Shareholders

Trevena Third Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
PCSA

Simply Wall St.

2 years ago

Trevena Third Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags

Polar Asset Management Partners Inc. Adjusts Stake in GEN Restaurant Group Inc.
PCSA

GuruFocus.com

2 years ago

Polar Asset Management Partners Inc. Adjusts Stake in GEN Restaurant Group Inc.

Intuitive Machines, Inc. (NASDAQ:LUNR) Q3 2023 Earnings Call Transcript
PCSA

Insider Monkey

2 years ago

Intuitive Machines, Inc. (NASDAQ:LUNR) Q3 2023 Earnings Call Transcript

Airgain Expands Distribution into Australasia with Logic Wireless Partnership
PCSA

Business Wire

2 years ago

Airgain Expands Distribution into Australasia with Logic Wireless Partnership

Airgain® Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PCSA

Business Wire

2 years ago

Airgain® Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Here's Why Shareholders May Want To Be Cautious With Increasing Genetic Technologies Limited's (ASX:GTG) CEO Pay Packet
PCSA

Simply Wall St.

2 years ago

Here's Why Shareholders May Want To Be Cautious With Increasing Genetic Technologies Limited's (ASX:GTG) CEO Pay Packet

BT Brands Reports Third Quarter 2023 Results
PCSA

Business Wire

2 years ago

BT Brands Reports Third Quarter 2023 Results

Share on Social Networks: